跳至主要内容
临床试验/DRKS00013026
DRKS00013026招募中未知

Randomized Controlled Trial to Compare Hybrid-Argon-Plasma-Coagulation (Hybrid-APC) and Radiofrequencyablation in Treatment of Barrett´s esophagus with Low-Grade Intraepithelial Neoplasia and High-Grade Intraepithelial Neoplasia or After Primary Endoscopic Resection of Early Cancer in the Esophagus.

Sana Klinikum Offenbach0 个研究点目标入组 314 人开始时间: 2017年11月28日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
314

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patients with Barrett´s mucosa after endoscopic resection of all visible lesions. Barrett´s length = 1 cm with maximum of high-grade intraepithelial neoplasia.
  • Patients without visible lesions after carefully inspection by second endscopy (High -definition endoscopes and chromoendoscopy) and confirmed intraepithelial neoplasia by a second pathologist.

排除标准

  • Age under 18 years and over 85 years
  • Patients unable to give consent
  • Pregnancy
  • Insufficiant endoscopic therapy after more than 3 endoscopic interventions.
  • Patients after radiofrequency ablation, Argon-plasma-coagulation or any other ablativ therapy
  • Patient with non-dysplastic Barrett´s esophagus
  • Barrett length < 1cm
  • Patients with severe esophageal stenosis after endoscopic resection.
  • Patients with diagnosis of non currative severe carcinoma
  • Patients with coagulation disorder
  • Missing written consent

研究者

发起方
Sana Klinikum Offenbach

相似试验